267 related articles for article (PubMed ID: 33619557)
41. ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies.
Mesuraca M; Chiarella E; Scicchitano S; Codispoti B; Giordano M; Nappo G; Bond HM; Morrone G
Biomed Res Int; 2015; 2015():165238. PubMed ID: 26788497
[TBL] [Abstract][Full Text] [Related]
42. Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia.
Liu GJ; Cimmino L; Jude JG; Hu Y; Witkowski MT; McKenzie MD; Kartal-Kaess M; Best SA; Tuohey L; Liao Y; Shi W; Mullighan CG; Farrar MA; Nutt SL; Smyth GK; Zuber J; Dickins RA
Genes Dev; 2014 Jun; 28(12):1337-50. PubMed ID: 24939936
[TBL] [Abstract][Full Text] [Related]
43. PAX5 promotes pre-B cell proliferation by regulating the expression of pre-B cell receptor and its downstream signaling.
Xue K; Song J; Yang Y; Li Z; Wu C; Jin J; Li W
Mol Immunol; 2016 May; 73():1-9. PubMed ID: 27016671
[TBL] [Abstract][Full Text] [Related]
44. LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients.
Cazzaniga V; Bugarin C; Bardini M; Giordan M; te Kronnie G; Basso G; Biondi A; Fazio G; Cazzaniga G
Oncotarget; 2015 Jan; 6(3):1569-81. PubMed ID: 25595912
[TBL] [Abstract][Full Text] [Related]
45. Paired box gene 5 isoforms A and B have different functions in transcriptional regulation of B cell development-related genes in immature B cells.
Kikuchi H; Nakayama M; Kuribayashi F; Mimuro H; Imajoh-Ohmi S; Nishitoh H; Takami Y; Nakayama T
Microbiol Immunol; 2015 Jul; 59(7):426-31. PubMed ID: 26094714
[TBL] [Abstract][Full Text] [Related]
46. Comprehensive Proteomic Investigation of Ebf1 Heterozygosity in Pro-B Lymphocytes Utilizing Data Independent Acquisition.
Musa YR; Boller S; Puchalska M; Grosschedl R; Mittler G
J Proteome Res; 2018 Jan; 17(1):76-85. PubMed ID: 29181981
[TBL] [Abstract][Full Text] [Related]
47. Interplay between transcription regulators RUNX1 and FUBP1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation.
Debaize L; Jakobczyk H; Avner S; Gaudichon J; Rio AG; Sérandour AA; Dorsheimer L; Chalmel F; Carroll JS; Zörnig M; Rieger MA; Delalande O; Salbert G; Galibert MD; Gandemer V; Troadec MB
Nucleic Acids Res; 2018 Nov; 46(21):11214-11228. PubMed ID: 30500954
[TBL] [Abstract][Full Text] [Related]
48. PAX5 is a tumor suppressor in mouse mutagenesis models of acute lymphoblastic leukemia.
Dang J; Wei L; de Ridder J; Su X; Rust AG; Roberts KG; Payne-Turner D; Cheng J; Ma J; Qu C; Wu G; Song G; Huether RG; Schulman B; Janke L; Zhang J; Downing JR; van der Weyden L; Adams DJ; Mullighan CG
Blood; 2015 Jun; 125(23):3609-17. PubMed ID: 25855603
[TBL] [Abstract][Full Text] [Related]
49. Runx1-Cbfβ facilitates early B lymphocyte development by regulating expression of Ebf1.
Seo W; Ikawa T; Kawamoto H; Taniuchi I
J Exp Med; 2012 Jul; 209(7):1255-62. PubMed ID: 22665574
[TBL] [Abstract][Full Text] [Related]
50. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5.
Pongubala JM; Northrup DL; Lancki DW; Medina KL; Treiber T; Bertolino E; Thomas M; Grosschedl R; Allman D; Singh H
Nat Immunol; 2008 Feb; 9(2):203-15. PubMed ID: 18176567
[TBL] [Abstract][Full Text] [Related]
51. Efficient retroviral transduction of human B-lymphoid and myeloid progenitors: marked inhibition of their growth by the Pax5 transgene.
Sekine R; Kitamura T; Tsuji T; Tojo A
Int J Hematol; 2008 May; 87(4):351-362. PubMed ID: 18415655
[TBL] [Abstract][Full Text] [Related]
52. Pax5: a master regulator of B cell development and leukemogenesis.
Medvedovic J; Ebert A; Tagoh H; Busslinger M
Adv Immunol; 2011; 111():179-206. PubMed ID: 21970955
[TBL] [Abstract][Full Text] [Related]
53. A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate.
Lin YC; Jhunjhunwala S; Benner C; Heinz S; Welinder E; Mansson R; Sigvardsson M; Hagman J; Espinoza CA; Dutkowski J; Ideker T; Glass CK; Murre C
Nat Immunol; 2010 Jul; 11(7):635-43. PubMed ID: 20543837
[TBL] [Abstract][Full Text] [Related]
54. PAX5 epigenetically orchestrates CD58 transcription and modulates blinatumomab response in acute lymphoblastic leukemia.
Li Y; Moriyama T; Yoshimura S; Zhao X; Li Z; Yang X; Paietta E; Litzow MR; Konopleva M; Yu J; Inaba H; Ribeiro RC; Pui CH; Yang JJ
Sci Adv; 2022 Dec; 8(50):eadd6403. PubMed ID: 36516256
[TBL] [Abstract][Full Text] [Related]
55. C/EBPα induces Ebf1 gene expression in common lymphoid progenitors.
Barberi T; Cui C; Friedman AD
PLoS One; 2020; 15(12):e0244161. PubMed ID: 33332417
[TBL] [Abstract][Full Text] [Related]
56. The transcriptional cofactor TRIM33 prevents apoptosis in B lymphoblastic leukemia by deactivating a single enhancer.
Wang E; Kawaoka S; Roe JS; Shi J; Hohmann AF; Xu Y; Bhagwat AS; Suzuki Y; Kinney JB; Vakoc CR
Elife; 2015 Apr; 4():e06377. PubMed ID: 25919951
[TBL] [Abstract][Full Text] [Related]
57. Potential tumor suppressive function of miR-196b in B-cell lineage acute lymphoblastic leukemia.
Bhatia S; Kaul D; Varma N
Mol Cell Biochem; 2010 Jul; 340(1-2):97-106. PubMed ID: 20549547
[TBL] [Abstract][Full Text] [Related]
58. CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis.
Chung EY; Psathas JN; Yu D; Li Y; Weiss MJ; Thomas-Tikhonenko A
J Clin Invest; 2012 Jun; 122(6):2257-66. PubMed ID: 22546857
[TBL] [Abstract][Full Text] [Related]
59. Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study.
Coyaud E; Struski S; Prade N; Familiades J; Eichner R; Quelen C; Bousquet M; Mugneret F; Talmant P; Pages MP; Lefebvre C; Penther D; Lippert E; Nadal N; Taviaux S; Poppe B; Luquet I; Baranger L; Eclache V; Radford I; Barin C; Mozziconacci MJ; Lafage-Pochitaloff M; Antoine-Poirel H; Charrin C; Perot C; Terre C; Brousset P; Dastugue N; Broccardo C
Blood; 2010 Apr; 115(15):3089-97. PubMed ID: 20160164
[TBL] [Abstract][Full Text] [Related]
60. Immunologic regulation of bone development.
Horowitz MC; Lorenzo JA
Adv Exp Med Biol; 2007; 602():47-56. PubMed ID: 17966387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
